{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T18:07:04Z","timestamp":1792692424792,"version":"4.5.0"},"reference-count":111,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T00:00:00Z","timestamp":1766188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T00:00:00Z","timestamp":1766188800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100011096","name":"Jazz Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011096","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Sleep Med"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s44470-025-00007-1","type":"journal-article","created":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T16:26:37Z","timestamp":1766247997000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Idiopathic hypersomnia is a 24-hour disorder"],"prefix":"10.1007","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8900-3280","authenticated-orcid":false,"given":"Nancy","family":"Foldvary-Schaefer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4073-4036","authenticated-orcid":false,"given":"Kiran","family":"Maski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8729-5224","authenticated-orcid":false,"given":"Logan D.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0683-6506","authenticated-orcid":false,"given":"Yves","family":"Dauvilliers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,20]]},"reference":[{"key":"7_CR1","doi-asserted-by":"publisher","first-page":"101709","DOI":"10.1016\/j.smrv.2022.101709","volume":"66","author":"Y Dauvilliers","year":"2022","unstructured":"Dauvilliers Y, Bogan RK, Arnulf I, Scammell TE, St Louis EK, Thorpy MJ. Clinical considerations for the diagnosis of idiopathic hypersomnia. Sleep Med Rev. 2022;66:101709.","journal-title":"Sleep Med Rev"},{"key":"7_CR2","unstructured":"American Academy of Sleep Medicine. International classification of sleep disorders \u2013 third edition, text revision. Darien, IL: American Academy of Sleep Medicine; 2023."},{"issue":"8","key":"7_CR3","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.5664\/jcsm.8482","volume":"16","author":"J Acquavella","year":"2020","unstructured":"Acquavella J, Mehra R, Bron M, Suomi JMH, Hess GP. Prevalence of narcolepsy, other sleep disorders, and diagnostic tests from 2013\u20132016: insured patients actively seeking care. J Clin Sleep Med. 2020;16(8):1255\u201363.","journal-title":"J Clin Sleep Med"},{"issue":"6","key":"7_CR4","doi-asserted-by":"publisher","first-page":"562","DOI":"10.5664\/jcsm.27658","volume":"5","author":"M Ali","year":"2009","unstructured":"Ali M, Auger RR, Slocumb NL, Morgenthaler TI. Idiopathic hypersomnia: clinical features and response to treatment. J Clin Sleep Med. 2009;5(6):562\u20138.","journal-title":"J Clin Sleep Med"},{"issue":"6","key":"7_CR5","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1136\/jnnp.2008.161588","volume":"80","author":"Y Dauvilliers","year":"2009","unstructured":"Dauvilliers Y, Paquereau J, Bastuji H, Drouot X, Weil JS, Viot-Blanc V. Psychological health in central hypersomnias: the French Harmony study.J Neurol Neurosurg Psychiatry. 2009;80(6):636\u201341.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"7_CR6","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/j.mayocp.2020.08.033","volume":"96","author":"KD Gandhi","year":"2021","unstructured":"Gandhi KD, Mansukhani MP, Silber MH, Kolla BP. Excessive daytime sleepiness: a clinical review. Mayo Clin Proc. 2021;96(5):1288\u2013301.","journal-title":"Mayo Clin Proc"},{"key":"7_CR7","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.sleep.2021.01.031","volume":"80","author":"S Nevsimalova","year":"2021","unstructured":"Nevsimalova S, Susta M, Prihodova I, Maurovich Horvat E, Milata M, Sonka K. Idiopathic hypersomnia: a homogeneous or heterogeneous disease? Sleep Med. 2021;80:86\u201391.","journal-title":"Sleep Med"},{"key":"7_CR8","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.sleep.2020.08.034","volume":"75","author":"LM Trotti","year":"2020","unstructured":"Trotti LM, Ong JC, Plante DT, Friederich Murray C, King R, Bliwise DL. Disease symptomatology and response to treatment in people with idiopathic hypersomnia: initial data from the Hypersomnia Foundation Registry. Sleep Med. 2020;75:343\u20139.","journal-title":"Sleep Med"},{"issue":"2","key":"7_CR9","doi-asserted-by":"publisher","first-page":"617","DOI":"10.5664\/jcsm.9682","volume":"18","author":"AL Rassu","year":"2022","unstructured":"Rassu AL, Evangelista E, Barateau L, et al. Idiopathic hypersomnia severity scale to better quantify symptoms severity and their consequences in idiopathic hypersomnia. J Clin Sleep Med. 2022;18(2):617\u201329.","journal-title":"J Clin Sleep Med"},{"issue":"4","key":"7_CR10","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1212\/CON.0000000000000883","volume":"26","author":"LM Trotti","year":"2020","unstructured":"Trotti LM. Central disorders of hypersomnolence. Continuum. 2020;26(4):890\u2013907.","journal-title":"Continuum"},{"issue":"11","key":"7_CR11","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.3390\/brainsci12111491","volume":"12","author":"S Nevsimalova","year":"2022","unstructured":"Nevsimalova S, Skibova J, Galuskova K, et al. Central disorders of hypersomnolence: association with fatigue, depression and sleep inertia prevailing in women. Brain Sci. 2022;12(11):1491.","journal-title":"Brain Sci"},{"issue":"5","key":"7_CR12","doi-asserted-by":"publisher","first-page":"749","DOI":"10.5664\/jcsm.8344","volume":"16","author":"MG Miglis","year":"2020","unstructured":"Miglis MG, Schneider L, Kim P, Cheung J, Trotti LM. Frequency and severity of autonomic symptoms in idiopathic hypersomnia.J Clin Sleep Med. 2020;16(5):749\u201356.","journal-title":"J Clin Sleep Med"},{"issue":"4","key":"7_CR13","doi-asserted-by":"publisher","first-page":"643","DOI":"10.5664\/jcsm.11014","volume":"20","author":"R Rosenberg","year":"2024","unstructured":"Rosenberg R, Thorpy MJ, Doghramji K, Morse AM. Brain fog in central disorders of hypersomnolence: a review. J Clin Sleep Med. 2024;20(4):643\u201351.","journal-title":"J Clin Sleep Med"},{"issue":"3","key":"7_CR14","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.jsmc.2019.05.007","volume":"14","author":"I Arnulf","year":"2019","unstructured":"Arnulf I, Leu-Semenescu S, Dodet P. Precision medicine for idiopathic hypersomnia. Sleep Med Clin. 2019;14(3):333\u201350.","journal-title":"Sleep Med Clin"},{"key":"7_CR15","doi-asserted-by":"publisher","first-page":"593","DOI":"10.2147\/NSS.S396641","volume":"15","author":"J Stevens","year":"2023","unstructured":"Stevens J, Schneider LD, Husain A, et al. Impairment in functioning and quality of life in patients with idiopathic hypersomnia: the Real World Idiopathic Hypersomnia Outcomes Study (ARISE). Nat Sci Sleep. 2023;15:593\u2013606.","journal-title":"Nat Sci Sleep"},{"issue":"2","key":"7_CR16","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.sleep.2011.07.014","volume":"13","author":"A Ozaki","year":"2012","unstructured":"Ozaki A, Inoue Y, Hayashida K, et al. Quality of life in patients with narcolepsy with cataplexy, narcolepsy without cataplexy, and idiopathic hypersomnia without long sleep time: comparison between patients on psychostimulants, drug-na\u00efve patients and the general Japanese population. Sleep Med. 2012;13(2):200\u20136.","journal-title":"Sleep Med"},{"key":"7_CR17","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.sleep.2020.10.014","volume":"76","author":"HB Wasling","year":"2020","unstructured":"Wasling HB, Bornstein A, Wasling P. Quality of life and procrastination in post-H1N1 narcolepsy, sporadic narcolepsy and idiopathic hypersomnia, a Swedish cross-sectional study. Sleep Med. 2020;76:104\u201312.","journal-title":"Sleep Med"},{"issue":"8","key":"7_CR18","doi-asserted-by":"publisher","first-page":"789","DOI":"10.5664\/jcsm.2922","volume":"9","author":"LM Trotti","year":"2013","unstructured":"Trotti LM, Staab BA, Rye DB. Test-retest reliability of the multiple sleep latency test in narcolepsy without cataplexy and idiopathic hypersomnia. J Clin Sleep Med. 2013;9(8):789\u201395.","journal-title":"J Clin Sleep Med"},{"issue":"12","key":"7_CR19","doi-asserted-by":"publisher","first-page":"zsx164","DOI":"10.1093\/sleep\/zsx164","volume":"40","author":"R Lopez","year":"2017","unstructured":"Lopez R, Doukkali A, Barateau L, et al. Test-retest reliability of the multiple sleep latency test in central disorders of hypersomnolence. Sleep. 2017;40(12).","journal-title":"Sleep"},{"issue":"1","key":"7_CR20","doi-asserted-by":"publisher","first-page":"65","DOI":"10.5664\/jcsm.6882","volume":"14","author":"C Ruoff","year":"2018","unstructured":"Ruoff C, Pizza F, Trotti LM, et al. The MSLT is repeatable in narcolepsy type 1 but not narcolepsy type 2: a retrospective patient study. J Clin Sleep Med. 2018;14(1):65\u201374.","journal-title":"J Clin Sleep Med"},{"issue":"2","key":"7_CR21","doi-asserted-by":"publisher","first-page":"e207994","DOI":"10.1212\/WNL.0000000000207994","volume":"102","author":"DT Plante","year":"2024","unstructured":"Plante DT, Hagen EW, Barnet JH, Mignot E, Peppard PE. Prevalence and course of idiopathic hypersomnia in the Wisconsin sleep cohort study.Neurology. 2024;102(2):e207994.","journal-title":"Neurology"},{"issue":"4","key":"7_CR22","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.smrv.2013.08.002","volume":"18","author":"TB Kendzerska","year":"2014","unstructured":"Kendzerska TB, Smith PM, Brignardello-Petersen R, Leung RS, Tomlinson GA. Evaluation of the measurement properties of the Epworth Sleepiness Scale: a systematic review. Sleep Med Rev. 2014;18(4):321\u201331.","journal-title":"Sleep Med Rev"},{"issue":"1","key":"7_CR23","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.sleh.2019.09.004","volume":"6","author":"BP Kolla","year":"2020","unstructured":"Kolla BP, He JP, Mansukhani MP, Frye MA, Merikangas K. Excessive sleepiness and associated symptoms in the U.S. adult population: prevalence, correlates, and comorbidity. Sleep Health. 2020;6(1):79\u201387.","journal-title":"Sleep Health"},{"issue":"suppl 16","key":"7_CR24","first-page":"12","volume":"65","author":"TB Young","year":"2004","unstructured":"Young TB. Epidemiology of daytime sleepiness: definitions, symptomatology, and prevalence. J Clin Psychiatry. 2004;65(suppl 16):12\u20136.","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"7_CR25","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","volume":"14","author":"MW Johns","year":"1991","unstructured":"Johns MW. A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep. 1991;14(6):540\u20135.","journal-title":"Sleep"},{"issue":"15","key":"7_CR26","doi-asserted-by":"publisher","first-page":"e1754","DOI":"10.1212\/WNL.0000000000007264","volume":"92","author":"Y Dauvilliers","year":"2019","unstructured":"Dauvilliers Y, Evangelista E, Barateau L, et al. Measurement of symptoms in idiopathic hypersomnia: the Idiopathic Hypersomnia Severity Scale. Neurology. 2019;92(15):e1754\u201362.","journal-title":"Neurology"},{"key":"7_CR27","doi-asserted-by":"publisher","first-page":"89","DOI":"10.2147\/NSS.S386021","volume":"15","author":"LD Schneider","year":"2023","unstructured":"Schneider LD, Stevens J, Husain AM, et al. Symptom severity and treatment satisfaction in patients with idiopathic hypersomnia: the Real World Idiopathic Hypersomnia Outcomes Study (ARISE). Nat Sci Sleep. 2023;15:89\u2013101.","journal-title":"Nat Sci Sleep"},{"issue":"4","key":"7_CR28","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1111\/j.1365-2869.2010.00824.x","volume":"19","author":"C Vernet","year":"2010","unstructured":"Vernet C, Leu-Semenescu S, Buzare MA, Arnulf I. Subjective symptoms in idiopathic hypersomnia: beyond excessive sleepiness. J Sleep Res. 2010;19(4):525\u201334.","journal-title":"J Sleep Res"},{"issue":"10","key":"7_CR29","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1093\/sleep\/30.10.1274","volume":"30","author":"KN Anderson","year":"2007","unstructured":"Anderson KN, Pilsworth S, Sharples LD, Smith IE, Shneerson JM. Idiopathic hypersomnia: a study of 77 cases. Sleep. 2007;30(10):1274\u201381.","journal-title":"Sleep"},{"issue":"6","key":"7_CR30","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.5665\/sleep.3756","volume":"37","author":"CR Baumann","year":"2014","unstructured":"Baumann CR, Mignot E, Lammers GJ, et al. Challenges in diagnosing narcolepsy without cataplexy: a consensus statement. Sleep. 2014;37(6):1035\u201342.","journal-title":"Sleep"},{"issue":"12","key":"7_CR31","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.5664\/jcsm.11298","volume":"20","author":"J Anderson","year":"2024","unstructured":"Anderson J, Yee BJ, Grunstein R, et al. Insights from a 10-year Australasian idiopathic hypersomnia patient data registry study. J Clin Sleep Med. 2024;20(12):1955\u201364.","journal-title":"J Clin Sleep Med"},{"key":"7_CR32","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/B978-0-444-64142-7.00060-6","volume":"161","author":"L Barateau","year":"2019","unstructured":"Barateau L, Lopez R, Dauvilliers Y. Clinical neurophysiology of CNS hypersomnias. Handb Clin Neurol. 2019;161:353\u201367.","journal-title":"Handb Clin Neurol"},{"issue":"5","key":"7_CR33","doi-asserted-by":"publisher","first-page":"zsad323","DOI":"10.1093\/sleep\/zsad323","volume":"47","author":"L Barateau","year":"2024","unstructured":"Barateau L, Chenini S, Denis C, et al. Narcolepsy severity scale-2 and idiopathic hypersomnia severity scale to better quantify symptoms severity and consequences in narcolepsy type 2. Sleep. 2024;47(5):zsad323.","journal-title":"Sleep"},{"issue":"3","key":"7_CR34","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.jsmc.2022.06.016","volume":"17","author":"I Arnulf","year":"2022","unstructured":"Arnulf I, Leu-Semenescu S, Dodet P. Precision medicine for idiopathic hypersomnia. Sleep Med Clin. 2022;17(3):379\u201398.","journal-title":"Sleep Med Clin"},{"issue":"4","key":"7_CR35","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1136\/jnnp-2022-329683","volume":"94","author":"L McWhirter","year":"2023","unstructured":"McWhirter L, Smyth H, Hoeritzauer I, Couturier A, Stone J, Carson AJ. What is brain fog? J Neurol Neurosurg Psychiatry. 2023;94(4):321\u20135.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"7_CR36","doi-asserted-by":"publisher","first-page":"zpae043","DOI":"10.1093\/sleepadvances\/zpae043","volume":"5","author":"BT Harel","year":"2024","unstructured":"Harel BT, Gattuso JJ, Latzman RD, Maruff P, Scammell TE, Plazzi G. The nature and magnitude of cognitive impairment in narcolepsy type 1, narcolepsy type 2, and idiopathic hypersomnia: a meta-analysis. Sleep Adv. 2024;5(1):zpae043.","journal-title":"Sleep Adv"},{"issue":"pt 8","key":"7_CR37","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1093\/brain\/120.8.1423","volume":"120","author":"C Bassetti","year":"1997","unstructured":"Bassetti C, Aldrich MS. Idiopathic hypersomnia. A series of 42 patients. Brain. 1997;120(pt 8):1423\u201335.","journal-title":"Brain"},{"issue":"14","key":"7_CR38","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1212\/WNL.0b013e31826d5f95","volume":"79","author":"A Parsaik","year":"2012","unstructured":"Parsaik A, Allison TG, Singer W, et al. Deconditioning in patients with orthostatic intolerance. Neurology. 2012;79(14):1435\u20139.","journal-title":"Neurology"},{"key":"7_CR39","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.sleep.2020.11.040","volume":"78","author":"S Jagadish","year":"2021","unstructured":"Jagadish S, Singer W, Kotagal S. Autonomic dysfunction in childhood hypersomnia disorders. Sleep Med. 2021;78:43\u20138.","journal-title":"Sleep Med"},{"issue":"2","key":"7_CR40","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/ana.25141","volume":"83","author":"E Evangelista","year":"2018","unstructured":"Evangelista E, Lopez R, Barateau L, et al. Alternative diagnostic criteria for idiopathic hypersomnia: a 32-hour protocol. Ann Neurol. 2018;83(2):235\u201347.","journal-title":"Ann Neurol"},{"issue":"1","key":"7_CR41","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S1474-4422(21)00368-9","volume":"21","author":"Y Dauvilliers","year":"2022","unstructured":"Dauvilliers Y, Arnulf I, Foldvary-Schaefer N, et al. Safety and efficacy of lower-sodium oxybate in adults with idiopathic hypersomnia: a phase 3, placebo-controlled, double-blind, randomised withdrawal study. Lancet Neurol. 2022;21(1):53\u201365.","journal-title":"Lancet Neurol"},{"issue":"6","key":"7_CR42","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1093\/sleep\/32.6.753","volume":"32","author":"C Vernet","year":"2009","unstructured":"Vernet C, Arnulf I. Idiopathic hypersomnia with and without long sleep time: a controlled series of 75 patients. Sleep. 2009;32(6):753\u20139.","journal-title":"Sleep"},{"issue":"6","key":"7_CR43","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.sleep.2011.03.010","volume":"12","author":"S Lavault","year":"2011","unstructured":"Lavault S, Dauvilliers Y, Drouot X, et al. Benefit and risk of modafinil in idiopathic hypersomnia vs. narcolepsy with cataplexy. Sleep Med. 2011;12(6):550\u20136.","journal-title":"Sleep Med"},{"key":"7_CR44","doi-asserted-by":"crossref","unstructured":"Adam T, Chenini S, Derre A, Barateau L, Dauvilliers Y. Sleep overestimation differentiates between participants with suspected idiopathic hypersomnia. Sleep. 2025. Online Ahead of Print.","DOI":"10.1093\/sleep\/zsaf131"},{"issue":"1\u20132","key":"7_CR45","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.neurol.2016.09.015","volume":"173","author":"S Leu-Semenescu","year":"2017","unstructured":"Leu-Semenescu S, Quera-Salva MA, Dauvilliers Y. French consensus. Idiopathic hypersomnia: investigations and follow-up. Rev Neurol (Paris). 2017;173(1\u20132):32\u20137.","journal-title":"Rev Neurol (Paris)"},{"issue":"3","key":"7_CR46","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.jsmc.2017.03.009","volume":"12","author":"LM Trotti","year":"2017","unstructured":"Trotti LM. Idiopathic hypersomnia. Sleep Med Clin. 2017;12(3):331\u201344.","journal-title":"Sleep Med Clin"},{"key":"7_CR47","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.smrv.2016.08.005","volume":"35","author":"LM Trotti","year":"2017","unstructured":"Trotti LM. Waking up is the hardest thing I do all day: sleep inertia and sleep drunkenness. Sleep Med Rev. 2017;35:76\u201384.","journal-title":"Sleep Med Rev"},{"issue":"1","key":"7_CR48","doi-asserted-by":"publisher","first-page":"zpae059","DOI":"10.1093\/sleepadvances\/zpae059","volume":"5","author":"T Boulanger","year":"2024","unstructured":"Boulanger T, Pigeon P, Crawford S. Diagnostic challenges and burden of idiopathic hypersomnia: a systematic literature review. Sleep Advances. 2024;5(1):zpae059.","journal-title":"Sleep Advances"},{"key":"7_CR49","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.sleep.2024.07.024","volume":"121","author":"ER Sung","year":"2024","unstructured":"Sung ER, Maness CB, Cook JD, et al. Validation and performance of the sleep inertia questionnaire in central disorders of hypersomnolence. Sleep Med. 2024;121:352\u20138.","journal-title":"Sleep Med"},{"issue":"7","key":"7_CR50","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.5664\/jcsm.11662","volume":"21","author":"RK Bogan","year":"2025","unstructured":"Bogan RK, Fuller DS, Whalen M, Casstevens C, Schneider LD. A minimal clinically important difference for the sleep inertia visual analog scale in idiopathic hypersomnia. J Clin Sleep Med. 2025;21(7):1209\u201316.","journal-title":"J Clin Sleep Med"},{"issue":"6","key":"7_CR51","doi-asserted-by":"publisher","first-page":"652","DOI":"10.3758\/BF03200977","volume":"17","author":"DF Dinges","year":"1985","unstructured":"Dinges DF, Powell JW. Microcomputer analyses of performance on a portable, simple visual RT task during sustained operations. Behav Res Methods Instrum Comput. 1985;17(6):652\u20135.","journal-title":"Behav Res Methods Instrum Comput"},{"issue":"9","key":"7_CR52","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.5664\/jcsm.4042","volume":"10","author":"J Thomann","year":"2014","unstructured":"Thomann J, Baumann CR, Landolt HP, Werth E. Psychomotor vigilance task demonstrates impaired vigilance in disorders with excessive daytime sleepiness. J Clin Sleep Med. 2014;10(9):1019\u201324.","journal-title":"J Clin Sleep Med"},{"issue":"1","key":"7_CR53","doi-asserted-by":"publisher","first-page":"zsab220","DOI":"10.1093\/sleep\/zsab220","volume":"45","author":"E Evangelista","year":"2022","unstructured":"Evangelista E, Rassu AL, Lopez R, et al. Sleep inertia measurement with the psychomotor vigilance task in idiopathic hypersomnia. Sleep. 2022;45(1):zsab220.","journal-title":"Sleep"},{"issue":"8","key":"7_CR54","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.5665\/sleep.4908","volume":"38","author":"F Pizza","year":"2015","unstructured":"Pizza F, Vandi S, Iloti M, et al. Nocturnal sleep dynamics identify narcolepsy type 1. Sleep. 2015;38(8):1277\u201384.","journal-title":"Sleep"},{"issue":"7","key":"7_CR55","doi-asserted-by":"publisher","first-page":"zsab021","DOI":"10.1093\/sleep\/zsab021","volume":"44","author":"KP Maski","year":"2021","unstructured":"Maski KP, Colclasure A, Little E, et al. Stability of nocturnal wake and sleep stages defines CNS disorders of hypersomnolence. Sleep. 2021;44(7):zsab021.","journal-title":"Sleep"},{"key":"7_CR56","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.sleep.2017.10.005","volume":"45","author":"DT Plante","year":"2018","unstructured":"Plante DT. Nocturnal sleep architecture in idiopathic hypersomnia: a systematic review and meta-analysis. Sleep Med. 2018;45:17\u201324.","journal-title":"Sleep Med"},{"issue":"1","key":"7_CR57","doi-asserted-by":"publisher","first-page":"16407","DOI":"10.1038\/s41598-024-67203-6","volume":"14","author":"AS Deshaies-Rugama","year":"2024","unstructured":"Deshaies-Rugama AS, Mombelli S, Blais H, et al. Sleep architecture in idiopathic hypersomnia: the influence of age, sex, and body mass index. Sci Rep. 2024;14(1):16407.","journal-title":"Sci Rep"},{"key":"7_CR58","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.nbscr.2019.02.001","volume":"6","author":"A Cairns","year":"2019","unstructured":"Cairns A, Bogan R. Comparison of the macro and microstructure of sleep in a sample of sleep clinic hypersomnia cases. Neurobiol Sleep Circadian Rhythms. 2019;6:62\u20139.","journal-title":"Neurobiol Sleep Circadian Rhythms"},{"issue":"6","key":"7_CR59","doi-asserted-by":"publisher","first-page":"572","DOI":"10.5664\/jcsm.27352","volume":"4","author":"A Ozaki","year":"2008","unstructured":"Ozaki A, Inoue Y, Nakajima T, et al. Health-related quality of life among drug-naive patients with narcolepsy with cataplexy, narcolepsy without cataplexy, and idiopathic hypersomnia without long sleep time. J Clin Sleep Med. 2008;4(6):572\u20138.","journal-title":"J Clin Sleep Med"},{"issue":"1","key":"7_CR60","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jsmc.2016.10.013","volume":"12","author":"P Saini","year":"2017","unstructured":"Saini P, Rye DB. Hypersomnia: evaluation, treatment, and social and economic aspects. Sleep Med Clin. 2017;12(1):47\u201360.","journal-title":"Sleep Med Clin"},{"key":"7_CR61","unstructured":"Reilly Associates.\u00a0WPAI scoring. 2022. Available at: http:\/\/www.reillyassociates.net\/WPAI_Scoring.html. Accessed 16 Mar 2022."},{"issue":"5","key":"7_CR62","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.sleep.2004.04.003","volume":"5","author":"L Vignatelli","year":"2004","unstructured":"Vignatelli L, D\u2019Alessandro R, Mosconi P, et al. Health-related quality of life in Italian patients with narcolepsy: the SF-36 health survey. Sleep Med. 2004;5(5):467\u201375.","journal-title":"Sleep Med"},{"issue":"6","key":"7_CR63","doi-asserted-by":"publisher","first-page":"e0129386","DOI":"10.1371\/journal.pone.0129386","volume":"10","author":"F Pizza","year":"2015","unstructured":"Pizza F, Jaussent I, Lopez R, et al. Car crashes and central disorders of hypersomnolence: a French study. PLoS ONE. 2015;10(6):e0129386.","journal-title":"PLoS ONE"},{"key":"7_CR64","unstructured":"American Academy of Sleep Medicine. Idiopathic hypersomnia. International classification of sleep disorders \u2013 third edition. Darien, IL: American Academy of Sleep Medicine; 2014."},{"issue":"7","key":"7_CR65","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.5664\/jcsm.7230","volume":"14","author":"MT Smith","year":"2018","unstructured":"Smith MT, McCrae CS, Cheung J, et al. Use of actigraphy for the evaluation of sleep disorders and circadian rhythm sleep-wake disorders: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment. J Clin Sleep Med. 2018;14(7):1231\u20137.","journal-title":"J Clin Sleep Med"},{"key":"7_CR66","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.smrv.2015.08.007","volume":"29","author":"M Billiard","year":"2016","unstructured":"Billiard M, Sonka K. Idiopathic hypersomnia. Sleep Med Rev. 2016;29:23\u201333.","journal-title":"Sleep Med Rev"},{"issue":"1","key":"7_CR67","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/ane.12504","volume":"134","author":"T Kim","year":"2016","unstructured":"Kim T, Lee JH, Lee CS, Yoon IY. Different fates of excessive daytime sleepiness: survival analysis for remission. Acta Neurol Scand. 2016;134(1):35\u201341.","journal-title":"Acta Neurol Scand"},{"issue":"3","key":"7_CR68","doi-asserted-by":"publisher","first-page":"zsz249","DOI":"10.1093\/sleep\/zsz249","volume":"43","author":"I Jaussent","year":"2020","unstructured":"Jaussent I, Morin CM, Ivers H, Dauvilliers Y. Natural history of excessive daytime sleepiness: a population-based 5-year longitudinal study. Sleep. 2020;43(3):zsz249.","journal-title":"Sleep"},{"issue":"2","key":"7_CR69","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1080\/13543784.2018.1417385","volume":"27","author":"E Evangelista","year":"2018","unstructured":"Evangelista E, Lopez R, Dauvilliers Y. Update on treatment for idiopathic hypersomnia. Expert Opin Investig Drugs. 2018;27(2):187\u201392.","journal-title":"Expert Opin Investig Drugs"},{"issue":"4","key":"7_CR70","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/pcn.13196","volume":"75","author":"M Honda","year":"2021","unstructured":"Honda M, Kimura S, Sasaki K, Wada M, Ito W. Evaluation of pathological sleepiness by multiple sleep latency test and 24-hour polysomnography in patients suspected of idiopathic hypersomnia. Psychiatry Clin Neurosci. 2021;75(4):149\u201351.","journal-title":"Psychiatry Clin Neurosci"},{"issue":"S1","key":"7_CR71","doi-asserted-by":"publisher","first-page":"17","DOI":"10.5664\/jcsm.8884","volume":"16","author":"LM Trotti","year":"2020","unstructured":"Trotti LM. Twice is nice? Test-retest reliability of the Multiple Sleep Latency Test in the central disorders of hypersomnolence. J Clin Sleep Med. 2020;16(S1):17\u20138.","journal-title":"J Clin Sleep Med"},{"issue":"4","key":"7_CR72","doi-asserted-by":"publisher","first-page":"597","DOI":"10.5664\/jcsm.7722","volume":"15","author":"JD Cook","year":"2019","unstructured":"Cook JD, Eftekari SC, Leavitt LA, Prairie ML, Plante DT. Optimizing actigraphic estimation of sleep duration in suspected idiopathic hypersomnia. J Clin Sleep Med. 2019;15(4):597\u2013602.","journal-title":"J Clin Sleep Med"},{"issue":"12","key":"7_CR73","doi-asserted-by":"publisher","first-page":"zsae189","DOI":"10.1093\/sleep\/zsae189","volume":"47","author":"F Biscarini","year":"2024","unstructured":"Biscarini F, Vandi S, Riccio C, et al. The actigraphic evaluation of daytime sleep in central disorders of hypersomnolence: comparison with polysomnography. Sleep. 2024;47(12):zsae189.","journal-title":"Sleep"},{"key":"7_CR74","doi-asserted-by":"crossref","unstructured":"Adam T, Tanty J, Barateau L, Dauvilliers Y. Actigraphy against 32-hour polysomnography in patients with suspected idiopathic hypersomnia. J Sleep Res. 2025;34(5):e70007.","DOI":"10.1111\/jsr.70007"},{"issue":"5","key":"7_CR75","doi-asserted-by":"publisher","first-page":"zsaa264","DOI":"10.1093\/sleep\/zsaa264","volume":"44","author":"E Evangelista","year":"2021","unstructured":"Evangelista E, Rassu AL, Barateau L, et al. Characteristics associated with hypersomnia and excessive daytime sleepiness identified by extended polysomnography recording. Sleep. 2021;44(5):zsaa264.","journal-title":"Sleep"},{"key":"7_CR76","unstructured":"Drachenberg C, Cambron-Mellott MJ, Yang L, Balkaran BL, Whalen M, Plante DT. The economic burden of idiopathic hypersomnia in the United States: analysis of the National Health and Wellness Survey [poster 436]. Presented at: Annual Scientific Meeting of the Associated Professional Sleep Societies; June 2\u20135, 2024; Houston, TX."},{"issue":"5","key":"7_CR77","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s10608-015-9686-4","volume":"39","author":"JC Kanady","year":"2015","unstructured":"Kanady JC, Harvey AG. Development and validation of the sleep inertia questionnaire (SIQ) and assessment of sleep inertia in analogue and clinical depression. Cognit Ther Res. 2015;39(5):601\u201312.","journal-title":"Cognit Ther Res"},{"issue":"11","key":"7_CR78","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.5664\/jcsm.8738","volume":"16","author":"BP Kolla","year":"2020","unstructured":"Kolla BP, Jahani Kondori M, Silber MH, Samman H, Dhankikar S, Mansukhani MP. Advance taper of antidepressants prior to multiple sleep latency testing increases the number of sleep-onset rapid eye movement periods and reduces mean sleep latency. J Clin Sleep Med. 2020;16(11):1921\u20137.","journal-title":"J Clin Sleep Med"},{"issue":"1","key":"7_CR79","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1093\/sleep\/28.1.113","volume":"28","author":"MR Littner","year":"2005","unstructured":"Littner MR, Kushida C, Wise M, et al. Practice parameters for clinical use of the multiple sleep latency test and the maintenance of wakefulness test. Sleep. 2005;28(1):113\u201321.","journal-title":"Sleep"},{"issue":"12","key":"7_CR80","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1136\/jnnp.74.12.1667","volume":"74","author":"Y Dauvilliers","year":"2003","unstructured":"Dauvilliers Y, Baumann CR, Carlander B, et al. CSF hypocretin-1 levels in narcolepsy, Kleine-Levin syndrome, and other hypersomnias and neurological conditions.J Neurol Neurosurg Psychiatry. 2003;74(12):1667\u201373.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"7_CR81","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.5665\/sleep.2114","volume":"35","author":"Y Dauvilliers","year":"2012","unstructured":"Dauvilliers Y, Delallee N, Jaussent I, et al. Normal cerebrospinal fluid histamine and tele-methylhistamine levels in hypersomnia conditions. Sleep. 2012;35(10):1359\u201366.","journal-title":"Sleep"},{"issue":"2","key":"7_CR82","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1093\/sleep\/32.2.181","volume":"32","author":"T Kanbayashi","year":"2009","unstructured":"Kanbayashi T, Kodama T, Kondo H, et al. CSF histamine contents in narcolepsy, idiopathic hypersomnia and obstructive sleep apnea syndrome. Sleep. 2009;32(2):181\u20137.","journal-title":"Sleep"},{"issue":"161","key":"7_CR83","doi-asserted-by":"publisher","first-page":"161ra151","DOI":"10.1126\/scitranslmed.3004685","volume":"4","author":"DB Rye","year":"2012","unstructured":"Rye DB, Bliwise DL, Parker K, et al. Modulation of vigilance in the primary hypersomnias by endogenous enhancement of GABAA receptors. Sci Transl Med. 2012;4(161):161ra151.","journal-title":"Sci Transl Med"},{"issue":"2","key":"7_CR84","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/ana.24710","volume":"80","author":"Y Dauvilliers","year":"2016","unstructured":"Dauvilliers Y, Evangelista E, Lopez R, et al. Absence of gamma-aminobutyric acid-a receptor potentiation in central hypersomnolence disorders. Ann Neurol. 2016;80(2):259\u201368.","journal-title":"Ann Neurol"},{"key":"7_CR85","doi-asserted-by":"publisher","first-page":"424","DOI":"10.3389\/fneur.2018.00424","volume":"9","author":"L Materna","year":"2018","unstructured":"Materna L, Halfter H, Heidbreder A, et al. Idiopathic hypersomnia patients revealed longer circadian period length in peripheral skin fibroblasts. Front Neurol. 2018;9:424.","journal-title":"Front Neurol"},{"issue":"4","key":"7_CR86","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s40675-019-00154-x","volume":"5","author":"D Landzberg","year":"2019","unstructured":"Landzberg D, Trotti LM. Is idiopathic hypersomnia a circadian rhythm disorder? Curr Sleep Med Rep. 2019;5(4):201\u20136.","journal-title":"Curr Sleep Med Rep"},{"key":"7_CR87","doi-asserted-by":"crossref","unstructured":"Adam T, Barateau L, Tanty J, Dauvilliers Y. Absence of dysregulation in amplitude and phase of circadian rhythm of core body temperature in idiopathic hypersomnia: A case-control study. Sleep. 2024. Online ahead of print.","DOI":"10.1093\/sleep\/zsae246"},{"issue":"5","key":"7_CR88","doi-asserted-by":"publisher","first-page":"e14146","DOI":"10.1111\/jsr.14146","volume":"33","author":"Y Cherasse","year":"2024","unstructured":"Cherasse Y, Taira Y, Rassu AL, et al. Association between idiopathic hypersomnia and a genetic variant in the PER3 gene. J Sleep Res. 2024;33(5):e14146.","journal-title":"J Sleep Res"},{"issue":"10","key":"7_CR89","doi-asserted-by":"publisher","first-page":"zsx140","DOI":"10.1093\/sleep\/zsx140","volume":"40","author":"S Boucetta","year":"2017","unstructured":"Boucetta S, Montplaisir J, Zadra A, et al. Altered regional cerebral blood flow in idiopathic hypersomnia. Sleep. 2017;40(10).","journal-title":"Sleep."},{"key":"7_CR90","doi-asserted-by":"publisher","first-page":"350","DOI":"10.3389\/fneur.2017.00350","volume":"8","author":"Y Dauvilliers","year":"2017","unstructured":"Dauvilliers Y, Evangelista E, de Verbizier D, Barateau L, Peigneux P. [18F]fludeoxyglucose-positron emission tomography evidence for cerebral hypermetabolism in the awake state in narcolepsy and idiopathic hypersomnia. Front Neurol. 2017;8:350.","journal-title":"Front Neurol"},{"key":"7_CR91","doi-asserted-by":"publisher","first-page":"663","DOI":"10.2147\/NSS.S412793","volume":"15","author":"LD Schneider","year":"2023","unstructured":"Schneider LD, Morse AM, Strunc MJ, Lee-Iannotti JK, Bogan RK. Long-term treatment of narcolepsy and idiopathic hypersomnia with low-sodium oxybate. Nat Sci Sleep. 2023;15:663\u201375.","journal-title":"Nat Sci Sleep"},{"key":"7_CR92","unstructured":"Xywav\u00ae (calcium, magnesium, potassium, and sodium oxybates) oral solution, CIII [prescribing information]. Palo Alto, CA: Jazz Pharmaceuticals, Inc.; 2025."},{"key":"7_CR93","unstructured":"U.S. Food & Drug Administration. FDA grants first of its kind indication for chronic sleep disorder treatment [press release]. 2021. Available at: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-grants-first-its-kind-indication-chronic-sleep-disorder-treatment. Accessed 17 Sept 2021."},{"key":"7_CR94","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.2147\/NSS.S369122","volume":"14","author":"MJ Thorpy","year":"2022","unstructured":"Thorpy MJ, Arnulf I, Foldvary-Schaefer N, et al. Efficacy and safety of lower-sodium oxybate in an open-label titration period of a phase 3 clinical study in adults with idiopathic hypersomnia.Nat Sci Sleep. 2022;14:1901\u201317.","journal-title":"Nat Sci Sleep"},{"issue":"suppl 1","key":"7_CR95","doi-asserted-by":"publisher","first-page":"A371","DOI":"10.1093\/sleep\/zsaf090.0856","volume":"48","author":"C Drachenberg","year":"2025","unstructured":"Drachenberg C, Cline J, D\u2019Souza J, et al. Real-world patient insights on low-sodium oxybate for idiopathic hypersomnia: interim results from LYRICAL [abstract 0856]. Sleep. 2025;48(suppl 1):A371\u20132.","journal-title":"Sleep"},{"issue":"9","key":"7_CR96","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.5664\/jcsm.9328","volume":"17","author":"K Maski","year":"2021","unstructured":"Maski K, Trotti LM, Kotagal S, et al. Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine clinical practice guideline.J Clin Sleep Med. 2021;17(9):1881\u201393.","journal-title":"J Clin Sleep Med"},{"key":"7_CR97","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.sleep.2021.01.018","volume":"80","author":"Y Inoue","year":"2021","unstructured":"Inoue Y, Tabata T, Tsukimori N. Efficacy and safety of modafinil in patients with idiopathic hypersomnia without long sleep time: a multicenter, randomized, double-blind, placebo-controlled, parallel-group comparison study. Sleep Med. 2021;80:315\u201321.","journal-title":"Sleep Med"},{"issue":"1","key":"7_CR98","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/jsr.12201","volume":"24","author":"G Mayer","year":"2015","unstructured":"Mayer G, Benes H, Young P, Bitterlich M, Rodenbeck A. Modafinil in the treatment of idiopathic hypersomnia without long sleep time\u2013a randomized, double-blind, placebo-controlled study. J Sleep Res. 2015;24(1):74\u201381.","journal-title":"J Sleep Res"},{"issue":"3","key":"7_CR99","doi-asserted-by":"publisher","first-page":"483","DOI":"10.5665\/sleep.3480","volume":"37","author":"P Philip","year":"2014","unstructured":"Philip P, Chaufton C, Taillard J, et al. Modafinil improves real driving performance in patients with hypersomnia: a randomized double-blind placebo-controlled crossover clinical trial. Sleep. 2014;37(3):483\u20137.","journal-title":"Sleep"},{"issue":"4","key":"7_CR100","doi-asserted-by":"publisher","first-page":"e12627","DOI":"10.1111\/jsr.12627","volume":"27","author":"C Thakrar","year":"2018","unstructured":"Thakrar C, Patel K, D\u2019Ancona G, et al. Effectiveness and side-effect profile of stimulant therapy as monotherapy and in combination in the central hypersomnias in clinical practice. J Sleep Res. 2018;27(4):e12627.","journal-title":"J Sleep Res"},{"issue":"9","key":"7_CR101","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.5664\/jcsm.9326","volume":"17","author":"K Maski","year":"2021","unstructured":"Maski K, Trotti LM, Kotagal S, et al. Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment. J Clin Sleep Med. 2021;17(9):1895\u2013945.","journal-title":"J Clin Sleep Med"},{"issue":"11","key":"7_CR102","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1007\/s40263-024-01122-y","volume":"38","author":"LM Trotti","year":"2024","unstructured":"Trotti LM, Blake T, Hoque R, Rye DB, Sharma S, Bliwise DL. Modafinil versus amphetamine-dextroamphetamine for idiopathic hypersomnia and narcolepsy type 2: a randomized, blinded, non-inferiority trial. CNS Drugs. 2024;38(11):909\u201320.","journal-title":"CNS Drugs"},{"issue":"3","key":"7_CR103","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/ana.24459","volume":"78","author":"LM Trotti","year":"2015","unstructured":"Trotti LM, Saini P, Bliwise DL, Freeman AA, Jenkins A, Rye DB. Clarithromycin in \u03b3-aminobutyric acid-related hypersomnolence: a randomized, crossover trial. Ann Neurol. 2015;78(3):454\u201365.","journal-title":"Ann Neurol"},{"issue":"6","key":"7_CR104","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.sleep.2014.01.021","volume":"15","author":"S Leu-Semenescu","year":"2014","unstructured":"Leu-Semenescu S, Nittur N, Golmard JL, Arnulf I. Effects of pitolisant, a histamine H3 inverse agonist, in drug-resistant idiopathic and symptomatic hypersomnia: a chart review. Sleep Med. 2014;15(6):681\u20137.","journal-title":"Sleep Med"},{"issue":"10","key":"7_CR105","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.5664\/jcsm.6196","volume":"12","author":"LM Trotti","year":"2016","unstructured":"Trotti LM, Saini P, Koola C, LaBarbera V, Bliwise DL, Rye DB. Flumazenil for the treatment of refractory hypersomnolence: clinical experience with 153 patients. J Clin Sleep Med. 2016;12(10):1389\u201394.","journal-title":"J Clin Sleep Med"},{"issue":"12","key":"7_CR106","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.5664\/jcsm.8088","volume":"15","author":"M Pascoe","year":"2019","unstructured":"Pascoe M, Bena J, Foldvary-Schaefer N. Effects of pharmacotherapy treatment on patient-reported outcomes in a narcolepsy and idiopathic hypersomnia cohort. J Clin Sleep Med. 2019;15(12):1799\u2013806.","journal-title":"J Clin Sleep Med"},{"issue":"11","key":"7_CR107","doi-asserted-by":"publisher","first-page":"e213690","DOI":"10.1212\/WNL.0000000000213690","volume":"104","author":"Y Dauvilliers","year":"2025","unstructured":"Dauvilliers Y, Chenini S, Thobois O, et al. Efficacy and safety of sodium oxybate in adults with idiopathic hypersomnia: a randomized controlled trial. Neurology. 2025;104(11):e213690.","journal-title":"Neurology"},{"key":"7_CR108","unstructured":"Xyrem\u00ae (sodium oxybate) oral solution, CIII [prescribing information]. Palo Alto, CA: Jazz Pharmaceuticals, Inc.; 2025."},{"issue":"3","key":"7_CR109","doi-asserted-by":"publisher","first-page":"zsaa206","DOI":"10.1093\/sleep\/zsaa206","volume":"44","author":"RK Bogan","year":"2021","unstructured":"Bogan RK, Thorpy MJ, Dauvilliers Y, et al. Efficacy and safety of calcium, magnesium, potassium, and sodium oxybates (lower-sodium oxybate [LXB]; JZP-258) in a placebo-controlled, double-blind, randomized withdrawal study in adults with narcolepsy with cataplexy. Sleep. 2021;44(3):zsaa206.","journal-title":"Sleep"},{"key":"7_CR110","doi-asserted-by":"crossref","unstructured":"Plante D, Grunstein R, Plazzi G, et al. Vibrance-3: study design and methods for a phase 2, randomized, placebo-controlled, parallel-group study evaluating the safety and efficacy of ALKS 2680 in patients with idiopathic hypersomnia [poster 538]. Presented at: Annual Scientific Meeting of the Associated Professional Sleep Societies; June 8\u201311, 2025; Houston, TX.","DOI":"10.1093\/sleepadvances\/zpaf053.093"},{"key":"7_CR111","unstructured":"Sunosi\u00ae (solriamfetol) tablets prescribing information. New York, NY, USA: Axsome Therapeutics, Inc.; 2023."}],"container-title":["Journal of Clinical Sleep Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44470-025-00007-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s44470-025-00007-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44470-025-00007-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T18:02:05Z","timestamp":1766253725000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s44470-025-00007-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,20]]},"references-count":111,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["7"],"URL":"https:\/\/doi.org\/10.1007\/s44470-025-00007-1","relation":{},"ISSN":["1550-9389","1550-9397"],"issn-type":[{"value":"1550-9389","type":"print"},{"value":"1550-9397","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,20]]},"assertion":[{"value":"24 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have seen and approved the manuscript and consent to its publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"This review does not report new data from a clinical trial.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial registration"}},{"value":"All N\/A.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Trial name, URL, ID number"}},{"value":"None.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Prior presentation"}},{"value":"N Foldvary-Schaefer\n                      has received research grants from Avadel, Jazz Pharmaceuticals, Harmony, Suven, Takeda, and Vanda; served on a publication committee and advisory committees for Jazz Pharmaceuticals; and received royalties from UpToDate and Oxford University Press.\n                      K Maski\n                      has received personal compensation for serving on advisory boards for Alkermes, Avadel, Eisai, Harmony Biosciences, Jazz Pharmaceuticals, and Takeda. She receives research support from Harmony Biosciences, Jazz Pharmaceuticals, and Takeda. She receives research support from National Institutes of Health, National Institute of Neurological Disorders and Stroke under award number\u00a0R61NS130215-01A1.\n                      LD Schneider\n                      has received personal compensation for serving on advisory boards and speakers bureaus for Avadel, Eisai, and Jazz Pharmaceuticals.\n                      Y Dauvilliers\n                      is a consultant for and has participated in advisory boards for Avadel, Bioprojet, Centessa, Harmony Biosciences, Idorsia, Jazz Pharmaceuticals, and Takeda.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6"}}